Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast Pichia pastoris

Details for Australian Patent Application No. 2010218139 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Davidson, Robert C.; Bobrowicz, Piotr; Zha, Dongxing

Agent Spruson & Ferguson

Pub. Number AU-B-2010218139

PCT Pub. Number WO2010/099153

Priority 61/208,582 25.02.09 US

Filing date 24 February 2010

Wipo publication date 2 September 2010

Acceptance publication date 1 November 2012

International Classifications

C12N 15/81 Mutation or genetic engineering - for yeasts

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/16 Micro-organisms, e.g. protozoa - Yeasts

C12N 9/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 9/90 Enzymes, e.g. ligases (6.) - Isomerases (5.)

C12N 15/54 Mutation or genetic engineering - Transferases (2)

C12N 15/61 Mutation or genetic engineering - Isomerases (5)

C12P 21/00 Preparation of peptides or proteins

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/099153 Priority application(s): WO2010/099153

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

1 November 2012 Application Accepted

  Published as AU-B-2010218139

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010218147-MicroRNAs in never-smokers and related materials and methods

2010218137-System and method of indicating transition between street level images